schliessen

Filtern

 

Bibliotheken

Global burden of blood-pressure-related disease, 2001

Summary Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg syst... Full description

Journal Title: The Lancet (British edition) 2008, Vol.371 (9623), p.1513-1518
Main Author: Lawes, Carlene MM, PhD
Other Authors: Hoorn, Stephen Vander, MSc , Rodgers, Anthony, Prof
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 0140-6736
Link: https://www.ncbi.nlm.nih.gov/pubmed/18456100
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_69173930
title: Global burden of blood-pressure-related disease, 2001
format: Article
creator:
  • Lawes, Carlene MM, PhD
  • Hoorn, Stephen Vander, MSc
  • Rodgers, Anthony, Prof
subjects:
  • Abridged Index Medicus
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Blood pressure
  • Cardiovascular disease
  • Cardiovascular Diseases - etiology
  • Cardiovascular Diseases - mortality
  • Data collection
  • Developing Countries
  • Estimates
  • Female
  • Global Health
  • Health risk assessment
  • Heart failure
  • Humans
  • Hypertension - complications
  • Hypertension - epidemiology
  • Hypertension - mortality
  • Internal Medicine
  • Male
  • Middle Aged
  • Mortality
  • Public health
  • Risk factors
  • Social Class
  • Studies
ispartof: The Lancet (British edition), 2008, Vol.371 (9623), p.1513-1518
description: Summary Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg systolic) was estimated for groups according to age (≥30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92 million DALYs (6·0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45–69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.7461016
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_69173930
sourceformatXML
sourcesystemPC
galeidA351012039
sourcerecordidA351012039
originalsourceidFETCH-LOGICAL-1569t-f0df38992078aa26f0d15f5d9ccdff33a474cfb1245a4f51d691a801a4ca80763
addsrcrecordideNqFkVFrFDEUhYModl39Ccrigyh06s3MJJNBUErRKhR8UMG3kElu1tRssiYzQv-92Z3F6r6UPFwSzvm4OYeQpxTOKFD--gvQFireNfwliFccOGOVuEcWtO3airXd9_tk8VdyQh7lfA0ALQf2kJxQ0TJOARaEXfo4KL8apmQwrKJdDT5GU20T5jwlrBJ6NaJZGZdRZTxd1QD0MXlglc_45DCX5NuH918vPlZXny8_XZxfVZTxfqwsGNuIvq-hE0rVvNwps8z0Whtrm0aVXbUdaN0y1VpGDe-pEkBVq8voeLMkL2buNsVfE-ZRblzW6L0KGKcsi75r-gaK8PmR8DpOKZTdJO17gJ6WGJbkbBatlUfpgo1jUrocgxunY0Dryvt5w0rANRTukpz-Yxim7EJJxYXs1j_GvFZTzv_L2SzXKeac0MptchuVbiQFuStN7kuTu0YkCLkvTYrie3ZYfho2aG5dh5aK4M0RWLtRjS6G8gHn78S_m91YmvrtMMmsHQaNxiXUozTR3Ul4e0TQ3gWnlf-JN5hvo5a5ljBDdgwQe4Jo_gCcZso9
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid199009167
display
typearticle
titleGlobal burden of blood-pressure-related disease, 2001
sourceAlma/SFX Local Collection
creatorLawes, Carlene MM, PhD ; Hoorn, Stephen Vander, MSc ; Rodgers, Anthony, Prof
creatorcontribLawes, Carlene MM, PhD ; Hoorn, Stephen Vander, MSc ; Rodgers, Anthony, Prof ; for the International Society of Hypertension ; International Society of Hypertension
descriptionSummary Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg systolic) was estimated for groups according to age (≥30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92 million DALYs (6·0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45–69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2DOI: 10.1016/S0140-6736(08)60655-8
3PMID: 18456100
4CODEN: LANCAO
languageeng
publisherEngland: Elsevier Ltd
subjectAbridged Index Medicus ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Blood pressure ; Cardiovascular disease ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - mortality ; Data collection ; Developing Countries ; Estimates ; Female ; Global Health ; Health risk assessment ; Heart failure ; Humans ; Hypertension - complications ; Hypertension - epidemiology ; Hypertension - mortality ; Internal Medicine ; Male ; Middle Aged ; Mortality ; Public health ; Risk factors ; Social Class ; Studies
ispartofThe Lancet (British edition), 2008, Vol.371 (9623), p.1513-1518
rights
0Elsevier Ltd
12008 Elsevier Ltd
2COPYRIGHT 2008 Elsevier B.V.
3Copyright Elsevier Limited May 3-May 9, 2008
lds50peer_reviewed
citedbyFETCH-LOGICAL-1569t-f0df38992078aa26f0d15f5d9ccdff33a474cfb1245a4f51d691a801a4ca80763
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18456100$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Lawes, Carlene MM, PhD
1Hoorn, Stephen Vander, MSc
2Rodgers, Anthony, Prof
3for the International Society of Hypertension
4International Society of Hypertension
title
0Global burden of blood-pressure-related disease, 2001
1The Lancet (British edition)
addtitleLancet
descriptionSummary Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg systolic) was estimated for groups according to age (≥30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92 million DALYs (6·0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45–69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
subject
0Abridged Index Medicus
1Adult
2Age Distribution
3Aged
4Aged, 80 and over
5Blood pressure
6Cardiovascular disease
7Cardiovascular Diseases - etiology
8Cardiovascular Diseases - mortality
9Data collection
10Developing Countries
11Estimates
12Female
13Global Health
14Health risk assessment
15Heart failure
16Humans
17Hypertension - complications
18Hypertension - epidemiology
19Hypertension - mortality
20Internal Medicine
21Male
22Middle Aged
23Mortality
24Public health
25Risk factors
26Social Class
27Studies
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2008
recordtypearticle
recordideNqFkVFrFDEUhYModl39Ccrigyh06s3MJJNBUErRKhR8UMG3kElu1tRssiYzQv-92Z3F6r6UPFwSzvm4OYeQpxTOKFD--gvQFireNfwliFccOGOVuEcWtO3airXd9_tk8VdyQh7lfA0ALQf2kJxQ0TJOARaEXfo4KL8apmQwrKJdDT5GU20T5jwlrBJ6NaJZGZdRZTxd1QD0MXlglc_45DCX5NuH918vPlZXny8_XZxfVZTxfqwsGNuIvq-hE0rVvNwps8z0Whtrm0aVXbUdaN0y1VpGDe-pEkBVq8voeLMkL2buNsVfE-ZRblzW6L0KGKcsi75r-gaK8PmR8DpOKZTdJO17gJ6WGJbkbBatlUfpgo1jUrocgxunY0Dryvt5w0rANRTukpz-Yxim7EJJxYXs1j_GvFZTzv_L2SzXKeac0MptchuVbiQFuStN7kuTu0YkCLkvTYrie3ZYfho2aG5dh5aK4M0RWLtRjS6G8gHn78S_m91YmvrtMMmsHQaNxiXUozTR3Ul4e0TQ3gWnlf-JN5hvo5a5ljBDdgwQe4Jo_gCcZso9
startdate2008
enddate2008
creator
0Lawes, Carlene MM, PhD
1Hoorn, Stephen Vander, MSc
2Rodgers, Anthony, Prof
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
90TT
100TZ
110U~
123V.
137QL
147QP
157RV
167TK
177U7
187U9
197X7
207XB
2188A
2288C
2388E
2488G
2588I
268AF
278AO
288C1
298C2
308FE
318FH
328FI
338FJ
348FK
358G5
36ABUWG
37AN0
38ASE
39AZQEC
40BBNVY
41BEC
42BENPR
43BHPHI
44C1K
45DWQXO
46FPQ
47FYUFA
48GHDGH
49GNUQQ
50GUQSH
51H94
52HCIFZ
53K6X
54K9-
55K9.
56KB0
57KB~
58LK8
59M0R
60M0S
61M0T
62M1P
63M2M
64M2O
65M2P
66M7N
67M7P
68MBDVC
69NAPCQ
70PQEST
71PQQKQ
72PQUKI
73Q9U
74S0X
757X8
sort
creationdate2008
titleGlobal burden of blood-pressure-related disease, 2001
authorLawes, Carlene MM, PhD ; Hoorn, Stephen Vander, MSc ; Rodgers, Anthony, Prof
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1569t-f0df38992078aa26f0d15f5d9ccdff33a474cfb1245a4f51d691a801a4ca80763
rsrctypearticles
prefilterarticles
languageeng
creationdate2008
topic
0Abridged Index Medicus
1Adult
2Age Distribution
3Aged
4Aged, 80 and over
5Blood pressure
6Cardiovascular disease
7Cardiovascular Diseases - etiology
8Cardiovascular Diseases - mortality
9Data collection
10Developing Countries
11Estimates
12Female
13Global Health
14Health risk assessment
15Heart failure
16Humans
17Hypertension - complications
18Hypertension - epidemiology
19Hypertension - mortality
20Internal Medicine
21Male
22Middle Aged
23Mortality
24Public health
25Risk factors
26Social Class
27Studies
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Lawes, Carlene MM, PhD
1Hoorn, Stephen Vander, MSc
2Rodgers, Anthony, Prof
3for the International Society of Hypertension
4International Society of Hypertension
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8News PRO
9Pharma and Biotech Premium PRO
10Global News & ABI/Inform Professional
11ProQuest Central (Corporate)
12Bacteriology Abstracts (Microbiology B)
13Calcium & Calcified Tissue Abstracts
14Nursing & Allied Health Database
15Neurosciences Abstracts
16Toxicology Abstracts
17Virology and AIDS Abstracts
18Health & Medical Collection
19ProQuest Central (purchase pre-March 2016)
20Biology Database (Alumni Edition)
21Healthcare Administration Database (Alumni)
22Medical Database (Alumni Edition)
23Psychology Database (Alumni)
24Science Database (Alumni Edition)
25STEM Database
26ProQuest Pharma Collection
27Public Health Database
28Lancet Titles
29ProQuest SciTech Collection
30ProQuest Natural Science Collection
31Hospital Premium Collection
32Hospital Premium Collection (Alumni Edition)
33ProQuest Central (Alumni) (purchase pre-March 2016)
34Research Library (Alumni Edition)
35ProQuest Central (Alumni Edition)
36British Nursing Database
37British Nursing Index
38ProQuest Central Essentials
39Biological Science Collection
40eLibrary
41ProQuest Central
42Natural Science Collection
43Environmental Sciences and Pollution Management
44ProQuest Central Korea
45British Nursing Index (BNI) (1985 to Present)
46Health Research Premium Collection
47Health Research Premium Collection (Alumni)
48ProQuest Central Student
49Research Library Prep
50AIDS and Cancer Research Abstracts
51SciTech Premium Collection
52British Nursing Index
53Consumer Health Database (Alumni Edition)
54ProQuest Health & Medical Complete (Alumni)
55Nursing & Allied Health Database (Alumni Edition)
56ProQuest Newsstand Professional
57ProQuest Biological Science Collection
58Consumer Health Database
59Health & Medical Collection (Alumni Edition)
60Healthcare Administration Database
61Medical Database
62Psychology Database
63Research Library
64Science Database
65Algology Mycology and Protozoology Abstracts (Microbiology C)
66Biological Science Database
67Research Library (Corporate)
68Nursing & Allied Health Premium
69ProQuest One Academic Eastern Edition
70ProQuest One Academic
71ProQuest One Academic UKI Edition
72ProQuest Central Basic
73SIRS Editorial
74MEDLINE - Academic
jtitleThe Lancet (British edition)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Lawes, Carlene MM, PhD
1Hoorn, Stephen Vander, MSc
2Rodgers, Anthony, Prof
aucorp
0for the International Society of Hypertension
1International Society of Hypertension
formatjournal
genrearticle
ristypeJOUR
atitleGlobal burden of blood-pressure-related disease, 2001
jtitleThe Lancet (British edition)
addtitleLancet
date2008
risdate2008
volume371
issue9623
spage1513
epage1518
pages1513-1518
issn0140-6736
eissn1474-547X
codenLANCAO
abstractSummary Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg systolic) was estimated for groups according to age (≥30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92 million DALYs (6·0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45–69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
copEngland
pubElsevier Ltd
pmid18456100
doi10.1016/S0140-6736(08)60655-8